Our Focus

The Psychedelic Research Group at Imperial focuses on two main research areas:  The action of psychedelic drugs in the brain. Their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression. The group is lead by Dr Robin Carhart-Harris.

Psychedelic Surveys 2018

Please take part in our global surveys! Imperial Psychedelic Research Group are proud to launch three new exciting surveys into the use of Psychedelics. Please visit either The Psychedelic Ceremony Study, The Global Psychedelic Survey or The Microdosing Survey Study. More information can be found at The Psychedelic Survey Website. We’d appreciate it if you …

Read morePsychedelic Surveys 2018

Magic mushrooms may ‘reset’ the brains of depressed patients

  Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a ‘reset’ of their brain activity. …     The findings come from a study in which researchers from Imperial College London used psilocybin – the psychoactive compound that occurs naturally in magic mushrooms – to treat a small number of …

Read moreMagic mushrooms may ‘reset’ the brains of depressed patients

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

This study was approved by the National Research Ethics Service (NRES) committee London – West London and was conducted in accordance with the revised declaration of Helsinki (2000), the International Committee on Harmonisation Good Clinical Practice (GCP) guidelines and National Health Service (NHS) Research Governance Framework. Imperial College London sponsored the research which was conducted …

Read morePsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Infographic: The Brain on Psychedelics

Infographic: The Brain on Psychedelics Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential. © CATHERINE DELPHIAKey brain areas involved in the effects of psychedelic drugs are located in the default mode network (DMN), which is more active at rest than when attention is focused on the external environment. Neuroscientists first discovered this …

Read moreInfographic: The Brain on Psychedelics

Can magic mushrooms treat depression? – New Scientist Live 2017

Could psychedelic drugs make the world a better place? In this talk, Robin Carhart-Harris will describe the rationale behind conducting the first ever clinical trial of psilocybin (magic mushrooms) as a treatment for depression – and share his results. Robin will describe how psilocybin works in the brain to have its antidepressant effects and discuss …

Read moreCan magic mushrooms treat depression? – New Scientist Live 2017

Psychedelics pioneer keeps his inner hippy in check

Psychedelics pioneer keeps his inner hippy in check   After giving people LSD and psilocybin, Robin Carhart-Harris is convinced of psychedelic therapy’s potential – but he daren’t get too excited about it .entry-header “I have conviction in psychedelics as tools to fundamentally understand the mind and the brain” Liz Hingley ONE of the last times …

Read morePsychedelics pioneer keeps his inner hippy in check